Val-Cit-PAB-DEA-Dxd
Val-Cit-PAB-DEA-Dxd (compound 81) is a Drug-Linker Conjugates for ADC, which is composed of a linker and a toxic molecule Dxd (DNA topoisomerase I inhibitor) . Val-Cit-PAB-DEA-Dxd can be used for ADC synthesis[1].
Product Specifications
CAS Number
2964543-53-9
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/val-cit-pab-dea-dxd.html
Solubility
10 mM in DMSO
Smiles
CC(C)[C@H](N)C(N[C@@H](CCCNC(N)=O)C(NC(C=C1)=CC=C1COC(N(C)CCN(C)C(OCC(N[C@@H]2C3=C4C(C(N5C4)=CC([C@](O)(C(OC6)=O)CC)=C6C5=O)=NC7=CC(F)=C(C)C(CC2)=C73)=O)=O)=O)=O)=O
Molecular Formula
C50H61FN10O12
Molecular Weight
1013.08
References & Citations
[1]Dechun Wu, et al. Pegylated antibody hydroxyl-bearing drug conjugate. Patent WO2023151679A1.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
